Ypsomed AG

Burgdorf, Switzerland

Ypsomed AG

Burgdorf, Switzerland

Time filter

Source Type

News Article | May 11, 2017
Site: www.PR.com

Global Self-Injections Market, By Type (Devices (Needle-Free, Auto, Pen, Wearable Injectors), Formulations), Dosage Form, Therapeutic Application, Route of Administration, End-User, Distribution Channel, Geography (North America, Europe, APAC, MEA, South America) – Trends and Forecast to 2024 Dallas, TX, May 11, 2017 --( The self-injections market is segmented based on type, dosage form, and therapeutic application, route of administration, end-user, distribution channel, and geography. Request for sample pages: http://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2024/ On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices. Based on therapeutic application, the self-injections market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. On the basis of dosage form, the market is segmented into single dose and multi-dose. Based on route of administration, the self-injections market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system. On the basis of end-user, the market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies. Based on geography, the self-injections market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. Read more: http://databridgemarketresearch.com/global-self-injectionsmarket-poised-grow-22-6/ The major players operating in this market are Abbvie, Inc., Antares Pharma, 3M,Becton Dickinson & Company, Baxter International Inc., Penjet Corporation, PharmaJet, GerresheimerAG, Pfizer Inc.,Terumo Corporation, Mylan N.V.,SHL Group, Bespak, Janssen Biotech Inc., Insulet Corporation, Unilife Corporation, West Pharmaceutical Services, Inc., Ypsomed, Eli lilly and Company, Haselmeier AG,Alkermes, AptarPharma,Credence MedSystems, Inc., SchottAG, Ypsomed, Owen Mumford Ltd., Glide Technologies, among other companies. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, May 11, 2017 --( PR.com )-- The global self-injections market is expected to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016 growing at the CAGR of 22.6 % in the forecast period 2017 to 2024.The self-injections market is segmented based on type, dosage form, and therapeutic application, route of administration, end-user, distribution channel, and geography.Request for sample pages: http://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2024/On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices.Based on therapeutic application, the self-injections market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others.On the basis of dosage form, the market is segmented into single dose and multi-dose.Based on route of administration, the self-injections market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.On the basis of end-user, the market is segmented into patient, physicians, home care settings and, others.The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies.Based on geography, the self-injections market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.Read more: http://databridgemarketresearch.com/global-self-injectionsmarket-poised-grow-22-6/The major players operating in this market are Abbvie, Inc., Antares Pharma, 3M,Becton Dickinson & Company, Baxter International Inc., Penjet Corporation, PharmaJet, GerresheimerAG, Pfizer Inc.,Terumo Corporation, Mylan N.V.,SHL Group, Bespak, Janssen Biotech Inc., Insulet Corporation, Unilife Corporation, West Pharmaceutical Services, Inc., Ypsomed, Eli lilly and Company, Haselmeier AG,Alkermes, AptarPharma,Credence MedSystems, Inc., SchottAG, Ypsomed, Owen Mumford Ltd., Glide Technologies, among other companies.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


·         Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic population, and rising awareness about insulin delivery devices are the major factors driving the growth of this market. ·         The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. ·         Key players in the global insulin delivery devices market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.). The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021). Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic population, and rising awareness about insulin delivery devices are the major factors driving the growth of this market. However, needle anxiety, emergence of oral drug delivery methods, and the growing trend of reuse of pen needles and infusion sets are the major factors restraining the growth of this market. Furthermore, increasing research and development activities and increasing diabetes-related health expenditure in emerging countries are likely to offer significant growth opportunities for players operating in the market. The global insulin delivery devices market is segmented on the basis of type, end user, and region. In 2016, North America accounted for the largest share of the market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is projected to have the highest growth rate in the forecast period. Factors such as rising prevalence of diabetes, high adoption of insulin pens, and government initiatives in Singapore are expected to support the growth of the Asia-Pacific insulin delivery devices market. The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, collaborations, agreements, partnerships, alliances, grants, joint ventures, acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market. In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the insulin delivery devices market. - By Company Type: Tier 1: 70%, Tier 2: 22%, Tier 3: 8% - By Designation: Director Level: 65%, C-level: 25%, Others: 10% - By Region: North America: 55%, Europe: 20%, APAC: 20%, RoW: 5% Key players in the global insulin delivery devices market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.). Research Coverage: This report studies the insulin delivery devices market based on type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions. Reasons to Buy the Report: The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one, or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers: • Market Penetration: Comprehensive information on the types of insulin delivery devices offered by top players in the insulin delivery devices market • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the insulin delivery devices market • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for insulin delivery devices across regions • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the insulin delivery devices market • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the insulin delivery devices market Read the full report: http://www.reportlinker.com/p04877067/Insulin-Delivery-Devices-Market-by-Type-Insulin-Pens-Reusable-Disposable-Insulin-Pumps-External-Tethered-Patch-Pen-Needles-Standard-Safety-Insulin-Syringes-and-End-User-Patients-Homecare-Hospitals-Clinics-Global-Forecast-to.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-insulin-delivery-devices-market-is-projected-to-reach-usd-1785-billion-by-2021-300453264.html


News Article | May 21, 2017
Site: www.PR.com

databridgemarketresearch.com presents "Global Pen Needles Market 2017.” It has accounted for USD 1.9 billion in 2016, and is expected to reach USD 4.5 billion by 2024 growing at a CAGR of 11.6% in the forecast period of 2017 to 2024. Dallas, TX, May 21, 2017 --( The Global Pen Needles Market is segmented on the basis of product type, product length, Usability, application, therapy, end-user and geography. Request for sample pages: http://databridgemarketresearch.com/reports/global-pen-needles-market/ The global pen needle market is segmented based on product type into standard and safety pen needles. The pen needles market is also segmented based on product length which varies from 4mm to 13mm in size. The pen needles segment by product length is long length, medium length and Nano length needles. Based on usability the global pen needles market is segmented into disposable and reusable pen needles. On the basis of application the global pen needles market is segmented into 3 indications diabetes, growth hormone deficiency and others. Based on the drug therapy the pen needles market is segmented into insulin, glucagon-like peptide-1 and growth hormones. Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. Read more: http://databridgemarketresearch.com/global-pen-needles-market-expected-reach-usd-3-6/ The major players operating in this market Becton, Dickinson and Company, ADW Diabetes, Novo Nordisk, A.Menarini Diagnostics, Ulticare, Ypsomed Holding AG, Facet Technologies, B. Braun Melsungen AG, Shanghai Neo-Medical Co. Ltd, HTL-Strefa S.A., Frank Healthcare Co., Ltd, Stat Medical Devices, Inc., Terumo Corporation, Domrex Pharma Inc., Vogt Medical Vertrieb GmbH, Artsana S.p.a, Eli Lilly, Owen Mumford Ltd, KD Medical GmbH Hospital Products, Allison Medical, Inc., Digital Medics Pty Ltd, and Ultimed, Inc. among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, May 21, 2017 --( PR.com )-- The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The Global Pen Needles Market is segmented on the basis of product type, product length, Usability, application, therapy, end-user and geography.Request for sample pages: http://databridgemarketresearch.com/reports/global-pen-needles-market/The global pen needle market is segmented based on product type into standard and safety pen needles.The pen needles market is also segmented based on product length which varies from 4mm to 13mm in size. The pen needles segment by product length is long length, medium length and Nano length needles.Based on usability the global pen needles market is segmented into disposable and reusable pen needles.On the basis of application the global pen needles market is segmented into 3 indications diabetes, growth hormone deficiency and others.Based on the drug therapy the pen needles market is segmented into insulin, glucagon-like peptide-1 and growth hormones.Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.Read more: http://databridgemarketresearch.com/global-pen-needles-market-expected-reach-usd-3-6/The major players operating in this market Becton, Dickinson and Company, ADW Diabetes, Novo Nordisk, A.Menarini Diagnostics, Ulticare, Ypsomed Holding AG, Facet Technologies, B. Braun Melsungen AG, Shanghai Neo-Medical Co. Ltd, HTL-Strefa S.A., Frank Healthcare Co., Ltd, Stat Medical Devices, Inc., Terumo Corporation, Domrex Pharma Inc., Vogt Medical Vertrieb GmbH, Artsana S.p.a, Eli Lilly, Owen Mumford Ltd, KD Medical GmbH Hospital Products, Allison Medical, Inc., Digital Medics Pty Ltd, and Ultimed, Inc. among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


News Article | May 18, 2017
Site: marketersmedia.com

— Market Highlights Global Insulin Delivery Devices Market to Expand at 6.9% CAGR during 2016-2020 The global insulin delivery devices market has been evaluated as steadily growing market. Globally, insulin delivery device is witnessing growth due to increase in prevalence of diabetes. With the increase in number of geriatric population, rising awareness of diabetes and technological advancement in delivery device are driving the growth of the market. Moreover, risk factors of type 2 diabetes and high blood pressure are increasing steadily with rise in prevalence of obesity. Nevertheless, due to the high cost of insulin and hazards and risks associated with delivery devices are inhibiting the growth of the market. Insulin is administered with the help of various delivery devices such as insulin pumps, pen injectors, insulin syringe and jet injectors. Most commonly used delivery system for self-medication purposes are Insulin syringes. However, some patient’s insulin syringe is not convenient option, which results in the development of other devices for the treatment of diabetes. global market for insulin delivery devices is growing rapidly and expected to reach USD 14.21 Billion by the end of 2020 With the increasing prevalence of diabetes, rising obesity endemic, increasing awareness among people about diabetic care and technological advancement in delivery devices are some of the factors influencing the growth of the insulin delivery device market. However, hazards and risks associated with delivery devices and high cost of insulin are inhibiting the growth of the insulin delivery device market. The prevalence of home infusion therapy and artificial pancreas are the major trends in insulin delivery devices market. North America dominates the global insulin delivery devices market due to rise in aging population and increasing prevalence of diabetes. On the other hand, Asia Pacific is expected to be the fastest growing region due to rising awareness of diabetic care and increasing healthcare expenditure. Globally, insulin syringe has captured the largest market share in insulin delivery devices market as it is a convenient mode of insulin administration. However, insulin pump is the fastest growing segment in the insulin delivery device market due to technological advancements in insulin pumps to maintain the level of insulin in the body for diabetic patients. Key Players for Insulin Delivery Devices Market: • F. Hoffmann-La Roche, • Eli Lilly and Company, • Sanofi, • Medtronic, Inc, • Novo Nordisk A/S and Becton, • Dickinson and Company, • B. Braun Melsungen AG, • Animas Corporation, • Ypsomed Holdings AG, • Insulet Corporation. Segmentation: Insulin delivery devices market has been segmented on the basis of type which comprises of Insulin Syringe, Insulin Pumps, Insulin Pens, and Insulin Jet Injectors. Regional Analysis: Depending on geographic region, insulin delivery devices market is segmented into four key regions which are North America, Europe, Asia Pacific, and Rest of World. Globally North America has captured the maximum market share for insulin delivery devices. The North America market for insulin delivery devices is expected to grow at CAGR 6.7% during the forecasted period. Europe is ranked as the second-largest market for insulin delivery devices which is expected to grow at a CAGR of 7.1%. Whereas, Asia pacific region is anticipated to be the fastest growing region in insulin delivery devices market. Table of Content 1. Research Scope and Methodology 11 1.1 Market Definition 11 1.2 Market Breakdown by Type 11 1.3 Market Breakdown by Geography 11 1.4 Research Methodology and Sources 12 2. Executive Summary 14 2.1 Key Findings 14 2.2 Research Summary 14 3. Market Outlook 16 3.1 Introduction 16 3.2 Trends in the Market 18 3.2.1 Home infusion therapy is achieving significance in the treatment of diabetes 18 3.2.2 Artificial pancreas is gaining popularity in the insulin delivery device market 18 3.3 Factors Driving the Market and its Impact on Market Forecast 19 Continue….. Related Report Chromatography systems Market information, by type (gas chromatography, liquid chromatography, and others), by end users (pharmaceutical and biotechnology industry, hospital and research laboratories, agriculture and food industry, and others) - Forecast to 2022.know more about this report @ https://www.marketresearchfuture.com/reports/chromatography-systems-market-2324 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. For more information, please visit https://www.marketresearchfuture.com


News Article | May 25, 2017
Site: www.prlog.org

Databridgemarketresearch.com presents "Global Pen Needles is expected to worth at CAGR of 11.6%", is projected to reach USD 4.5 billion. -- The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The Global Pen Needles Market is segmented into product type, product length, usability, application, therapy, and end-user and by geography.·         Standard Pen Needles·         Safety Pen Needles·         Nano Length·         Medium Length·         Long length·         Reusable Pen Needles·         Disposable Pen Needles·         Diabetes·         Growth Hormone Deficiency·         Insulin·         Glucagon-like peptide-1·         Growth Hormones·         Hospitals·         Clinics·         OTC·         Home HealthcareBased on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.·         Becton·         Dickinson and Company·         ADW Diabetes·         Novo Nordisk·         A.Menarini Diagnostics·         Ulticare·         Ypsomed Holding AG·         Facet Technologies·         B. Braun Melsungen AG·         Shanghai Neo-Medical Co. Ltd.·         HTL-Strefa S.A.·         Frank Healthcare Co., Ltd.·         Stat Medical Devices, Inc.·         Terumo Corporation·         Domrex Pharma Inc.·         Vogt Medical Vertrieb GmbH·         Artsana S.p.a·         Eli Lilly·         Owen Mumford Ltd·         KD Medical GmbH Hospital Products·         Allison Medical, Inc.·         Digital Medics Pty Ltd·         Ultimed, Inc.Data Bridge Market ResearchAmanora Chambers, Magarpatta Road,Hadapsar, Pune – 411028Tel: +1-888-387-2818Email: Sales@databridgemarketresearch.comVisit Data Bridge Blog@ http://databridgemarketresearch.com/blog/LinkedIn: https://www.linkedin.com/company/data-bridge-market-research


News Article | April 21, 2017
Site: marketersmedia.com

— The global pen needles market is expected to reach a value of USD 4.8 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of pen needles market. According to the International Diabetes Federation (IDF), nearly 415 million people were suffering from diabetes in 2015. Such a high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which helps in easy drug delivery. In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors of the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles. Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, in 2013, Becton, Dickinson and Company launched BD Ultra-Fine Nano 4mm Pen Needles with EasyFlow Technology, which will enable diabetic patients with easy adherence of insulin therapy regimens. Further Key Findings from the Study Suggest: Standard needles dominated the market in 2015 due to the availability of cost-effective needles as compared to safety needles. Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements. Amongst the needle lengths, 8mm held the largest share in 2015. This is due to the convenience offered by this needle type on diabetic patients. Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length. Insulin therapy accounted for the largest market share in 2015 due to rising awareness regarding self-administration of insulin amongst the diabetic patients. Europe dominated the market in 2015 followed by North America owing to high prevalence of diabetes in the European region. Asia Pacific region is anticipated to exhibit the highest growth rate over the forecast period owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery. Some of the key players include Becton, Dickinson and Company, B. Braun Melsungen AG, Novo Nordisk A/S, Owen Mumford, Ltd., Ypsomed, HTL-STREFA, and TERUMO CORPORATION. Chapter One: Research Methodology Chapter Two: Executive Summary Chapter Three: Pen Needles Market Variables, Trends & Scope Chapter Four: Pen Needles: Product Estimates & Trend Analysis Chapter Five: Pen Needles: Needle Length Estimates & Trend Analysis Chapter Six: Pen Needles: Therapy Estimates & Trend Analysis Chapter Seven: Pen Needles: Regional Estimates & Trend Analysis, by Product, Needle Length, Therapy Chapter Eight: Competitive Landscape About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients. For more information, please visit http://www.orbisresearch.com/reports/index/pen-needles-market-analysis-by-product-standard-pen-needles-safety-pen-needles-by-needle-length-4mm-5mm-6mm-8mm-10mm-12mm-by-therapy-insulin-glucagon-like-peptide-1-glp-1-growth-hormone-and-segment-forecasts-2014-2025


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2022" report to their offering. The research report titled Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2022 examines the market, demand, competitive landscape and trends of the ten major markets of the Insulin Pen Market. Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022. Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user-friendly design, rising popularity among consumers, help avoid over/under-dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices In terms of prefilled insulin pen users, China is the top prefilled insulin pen consumer, followed by United States and Japan, a trio leading a prefilled insulin pen users share and is expected to witness the highest growth rate in the forecast period United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period. In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022. In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period. The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market. Key Companies Covered in the Report are as follows: For more information about this report visit http://www.researchandmarkets.com/research/pgvbgj/insulin_pen


The research report titled Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2022 examines the market, demand, competitive landscape and trends of the ten major markets of the Insulin Pen Market. Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022. Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user-friendly design, rising popularity among consumers, help avoid over/under-dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices. In terms of prefilled insulin pen users, China is the top prefilled insulin pen consumer, followed by United States and Japan, a trio leading a prefilled insulin pen users share and is expected to witness the highest growth rate in the forecast period. United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period. In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022. In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period. The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market. Key Companies Covered in the Report are as follows: 1. Executive Summary 2. Insulin Pen Market in Top Ten Countries - Market Overview 3. Insulin Pen Market Drivers and Barriers 4. Insulin Pen Market in Top Ten Countries - Geographical Landscape 5. Key Companies Analysis For more information about this report visit http://www.researchandmarkets.com/research/s58sxk/insulin_pen To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-insulin-pen-market-2017-2022--market-is-likely-to-reach-more-than-us-12-billion-across-the-ten-major-markets-10mm-by-the-year-end-of-2022---research-and-markets-300452159.html


News Article | April 24, 2017
Site: marketersmedia.com

In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022.PUNE, INDIA - April 24, 2017 /MarketersMedia/ — Global Insulin Pen Industry Latest Report on Insulin Pen Market Global Analysis & 2022 Forecast Research Study Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022. Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices Try Sample Report @ https://www.wiseguyreports.com/sample-request/1214985-insulin-pen-market-size-share-opportunity-analysis-growth-potential-demand-forecast Insulin Pen Users Insights China is the leading consumers of insulin pen where XX% of the diabetic population prefer insulin pen. India and Germany have shown its potential to become 2nd and 3rd popular insulin pen users. United States is the fourth leading consumers of insulin pen. Japan and Brazil hold the fifth and sixth leading consumers of insulin pen. In terms of reusable insulin pen users, China gained its top position as the biggest overall consumer of reusable insulin pen. India and Germany grabbed the #2 and #3 position with XX% and XX% share in 2016 and is likely to maintain its position till the forecast period. Key Companies Covered in the Report are as follows 1. Novo Nordisk 2. Eli Lilly 3. Sanofi 4. Owen Mumford 5. Ypsomed 6. Biocon Ltd. In terms of prefilled insulin pen users, China is the top prefilled insulin pen consumer, followed by United States and Japan, a trio leading a prefilled insulin pen users share and is expected to witness the highest growth rate in the forecast period Insulin Pen Market Insights United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period. In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022. In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period. For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/1214985-insulin-pen-market-size-share-opportunity-analysis-growth-potential-demand-forecast The research report titled “Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the Insulin Pen Market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into insulin pen users with more focused–on reusable and prefilled insulin pen users. Market outlook in value terms for the forecasted period for Insulin Pen Market has been detailed in the report. The insulin pen market is further segment into reusable and prefilled insulin pen market. The report also explores detailed description of growth drivers and inhibitors of the Insulin Pen Market. The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market. All the Ten Major Markets(10MM) Covered in the Report Have Studied from 8 Viewpoints 1. Overall Diabetes Population (2011 – 2022) 2. Insulin Users (2011 – 2022) 3. Insulin Pen Users (2011 – 2022) 4. Reusable (Cartridge) Insulin Pen Users (2011 – 2022) 5. Prefilled (Disposable) Insulin Pen Users (2011 – 2022) 6. Insulin Pen Market (2011 – 2022) 7. Reusable (Cartridge) Insulin Pen Market (2011 – 2022) 8. Prefilled (Disposable) Insulin Pen Market (2011 – 2022) Ten Major Markets(10MM) Covered in the Report are as follows 1. United States 2. United Kingdom 3. France 4. Italy 5. Spain 6. Germany 7. Japan 8. China 9. India 10. Brazil If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/1214985-insulin-pen-market-size-share-opportunity-analysis-growth-potential-demand-forecast For more information or any query mail at sales@wiseguyreports.com About Us Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. Contact Us: Norah Trent +1 646 845 9349 / +44 208 133 9349 Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym Contact Info:Name: NORAH TRENTEmail: sales@wiseguyreports.comOrganization: WISE GUY RESEARCH CONSULTANTS PVT LTDSource URL: http://marketersmedia.com/insulin-pen-global-industry-size-share-trends-analysis-and-forecast-2017-2022/189482For more information, please visit https://www.wiseguyreports.com/sample-request/1214985-insulin-pen-market-size-share-opportunity-analysis-growth-potential-demand-forecastSource: MarketersMediaRelease ID: 189482


Research and Markets has announced the addition of the "Infusion Pumps - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Infusion Pumps in US$ by the following Product Segments: The report profiles 52 companies including many key and niche players such as: - Infusion Pumps: An Alternate Drug Delivery Option - Current and Future Analysis - Developed Economies Dominate Infusion Pumps Market - Asia-Pacific: The Fastest Growing Market for Infusion Pumps - Analysis by Product Segments - Ambulatory Infusion Pumps - Enteral Feeding Pumps - Insulin Infusion Pumps - Large Volume Infusion Pumps - PCA Infusion Pumps - Syringe Infusion Pumps - Infusion Errors & Technology Defenses Developed Over the Years - Rise in Incidence of Chronic Diseases Fuels Infusion Pumps Demand - The Diabetes Epidemic - Untapped Potential for Insulin Pumps - Global Diabetes Expenditure: Opportunity Indicator for Insulin Pumps Market - Cancer Pain Offers Potential Opportunities for Pain Management Pumps - Infusion Pumps - A Highly Consolidated Market - Insulin Pumps Market - Competition Intensifies - Comparison of Select Durable Insulin Pumps by Manufacturer - Medtronic Banks on New Solutions and Distribution Expansion to Retain Dominance - J&J's OneTouch Via - A Discrete Solution for On-Demand Insulin - Ypsomed Eyes Brighter Prospects with YpsoPump - Medtrum - A New Entrant with a Strong Product; Threatening to Take the Market by Storm - Competitive Landscape in the Insulin Patch Pump Market - OmniPod Benefits from Lack of Close Competition in its League - Insulet Focuses on Advances in Technology and Services to Gain Market Share - Cellnovo's Patch Pump Combines Functionality and Cost- Effectiveness - V-Go - An Affordable Patch Pump for Type II Diabetics - Expiry of Warranty Provides New Opportunities to Insulin Pump Makers - Customer Satisfaction: Crucial to Stay Competitive - Enteral Feeding Devices: An Intensely Competitive Market - Multinationals Target Emerging Markets - The New Hotspots for Growth - Infusion Errors: A Key Driving Force for Newer Technologies - Manufacturers Focus on Interoperability with EMR Systems - Security of Wireless Medical Device - A Vital Factor - Shift from Hospital Environments to Alternative-Sites/ Home Settings Drives the market for Home Infusion Pumps - Product Complexity Thwarts ROI on Devices - Smart Pump Technology: A Major Growth Driver - Smart Pumps with Innovative Features - Improving Functionality for Enhanced Patient Compliance - Maintaining Smartness Quotient of Smart Infusion Pumps - Product Bundling: A Double Whammy Success - Analgesia Infusion Pumps Continue to Register Favorable Growth - Disposable Ambulatory Infusion Pumps Market Exhibits Notable Stride Forward - Enteral Feeding Pumps Market Overview - Replacements Offer Potential Growth Opportunities - Preference for Enteral Nutrition over Parenteral Nutrition Bodes Well - Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition - Enteral Nutrition Therapy in Treating Adult Malnutrition Offers Growth Opportunities - Home Enteral Therapy to Boost Demand for Enteral Feeding Devices - Insulin Pumps - Designed for Optimum Disease Management - The Rise of Smart Pumps - Manufacturers Eye Type II Diabetes Market - Implantable Insulin Pumps - The Next Generation of Insulin Pumps - Patch Pumps Gain Manufacturer Attention - Insulin Pump Training - An Important Driver - Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged - Competition from Other Insulin Delivery Technologies Continues - Maturity Hits Volumetric Infusion Pumps Market - Equipment Recalls Thwarts Growth Prospects - Stringent Safety Regulations Impede Time-to-Market - Look into Select Technology Advancements - Ivenix Develops Next-Generation Infusion Management Platform - Innovfusion Develops Advanced Infusion Pumps to Provide Relief from Labor Pain - Summit Medical's Low-Cost Portable Infusion Pumps Improve Patient Care - Product Malfunctioning Erodes Penetration of Implantable Infusion Pumps Rise in Healthcare Spending in Developing Nations Bode Well for the Market Aging Population: A Strong Growth Driver Global Aging Population Statistics Opportunity Indicators Rise in Incidence of Cancer and Central Nervous System Diseases Foster Growth World Cancer Statistics: Incidence and Mortality Data Diabetes Incidence and Prevalence Global Diabetic Statistics Opportunity Indicators Alarming Rise in Obesity A Business Case for Diabetes Care Rise in HIV Prevalence Provides Ample Growth Opportunities Global HIV Statistics Opportunity Indicators for Enteral Feeding Devices - FDA Announces Initiative to Address Safety Concerns Related to Infusion Pumps - FDA Announces a New Mandate for Manufacturing Companies - Regulations Promote Adoption of Premium-Priced Safety Devices - ISO 80369 Standards for Small-Bore Connector - ENFit - The New ISO Standard Enteral Feeding Connecting System - Infusion Pumps: A Definition - Types of Infusion Pumps - Ambulatory Infusion Pumps - Non-Electronic Ambulatory Infusion Pumps - Advantages & Disadvantages of Non-Electronic Pumps - Electronic Ambulatory Infusion Pumps - Nerve Block Infusion Pumps - Enteral Feeding Pumps - Insulin Infusion Pumps - Large Volume Infusion Pumps - Pump Architecture of Volumetric Pumps - Classification by End-Use Application - Volumetric Pumps used in Acute Care Settings - Volumetric Pumps used in Alternate Care Settings - Patient Controlled Analgesic (PCA) Pumps - Syringe Infusion Pumps - Low-End and High-End Syringe Pumps - Implantable Infusion Pumps - Programmable Implantable Infusion Pumps - Constant Flow Implantable Infusion Pumps - Approved Applications of Implantable Infusion Pumps - Common Safety Features Available In Most Infusion Pumps - Key Problems Reported with Infusion Pumps - User Interface Issues - Software Issues - Alarm Errors - Damaged Components - Battery Failures - Fire, Shocks, Sparks or Charring - Intelligraphics Enters into Collaboration with Ivenixto Develop Intelligent Infusion Pump Platform - Smiths Medical Introduces New Software Version for use with Medfusion® 4000 wireless syringe pumps - Caesarea Medical Announces Launch of its latest Dual Channel Infusion Pump - Medtronic Launches MiniMed® 630G System - Hospira Introduces LifeCare PCA 7.0 infusion pump with EMR Connectivity - Smiths Medical Launches New CADD®-Solis Pump - Animas Bags FDA Approval for Animas® Vibe® Insulin Pump and Continuous Glucose Monitoring System - Medtronic Rolls Out MiniMed 640G Insulin Pump - B. Braun Medical Secures FDA Approval for Infusomat® Space Pump - Zyno Medical Gains CE Mark Approval for Z-800 Infusion Pump System - Hospira Receives FDA Clearance for Plum 360 Infusion System - BioLeonhardt Develops Stem Cell Pump - Animas Rolls Out Animas® Vibe Insulin Pump with Latest Dexcom CGM Technology - Baxter Gets FDA Clearance for SIGMA Spectrum Infusion Pump with Master Drug Library - Animas Bags CE Mark Approval for Animas® Vibe Insulin Pump and Dexcom G4 PLATINUM CGM System - Animas Secures FDA Approval for Animas® Vibe Insulin Pump and Continuous Glucose Monitoring System Omnicell and Hospira Collaborate for System Interoperability BD Enters into Collaboration with JDRF to Develop Extended Wear Innovations for Insulin Infusion Delivery Teleflex Signs Group Purchasing Agreement with Premier Inc. for Implantable Infusion Ports ICU Medical to Acquire Pfizer's Infusion Therapy Business Zyno Medical Receives FDA 510(k) Clearance for Nimbus II Ambulatory Infusion System InfuSystem to Acquire Infusion Pump Assets from InfusAID, LLC Medtronic to Manufacture and Deploy Advanced Diabetes Therapies in Chengdu, China Pfizer Considers Sale of the Infusion Pump Business Pfizer Acquires Hospira InfuSystem Completes Acquisition of Ciscura Becton Dickinson Takes Over CareFusion Hospira Inks Agreement with Cerner for Developing Infusion Pump Information Platform Animas Partners with Tidepool Medtronic Partners with BD to Develop New Insulin Pump with BD FlowSmart Technology Fresenius Kabi Inks Agreement with Amerinet Hospira Faces Class I Recall of GemStar Infusion System - Animas Corporation (USA) - Baxter International Inc. (USA) - B. Braun Melsungen AG (Germany) - Becton, Dickinson and Company (USA) - F. Hoffmann-La Roche Ltd. (Switzerland) - Fresenius SE & Co. KGaA (Germany) - Halyard Health, Inc. (USA) - Hospira, Inc. (USA) - ICU Medical, Inc. (USA) - Insulet Corporation (USA) - Medtronic, PLC (Ireland) - Moog, Inc. (USA) - Smiths Medical (USA) - Sooil Development Co. Ltd. (Korea) - Tandem Diabetes Care, Inc. (USA) - Teleflex Incorporated (USA) - Terumo Corporation (Japan) - The United States - Japan - Europe - France - Germany - The United Kingdom - Rest of Europe - Asia-Pacific (Excluding Japan) - Middle East - Latin America For more information about this report visit http://www.researchandmarkets.com/research/cq3cv2/infusion_pumps

Loading Ypsomed AG collaborators
Loading Ypsomed AG collaborators